EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2022 • Centessa Pharmaceuticals PLC • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 30th, 2022 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is made by and between Centessa Pharmaceuticals, Inc. (the “U.S. Subsidiary”), a wholly owned subsidiary of Centessa Pharmaceuticals plc (“Parent”, with Parent, the U.S. Subsidiary and their respective subsidiaries and other affiliates referred to herein as the “Company”) and Saurabh Saha (the “Executive”) and is effective as of March 30, 2022 (the “Effective Date”). This Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the employment offer letter between the Executive and the Company dated as of November 19, 2020, revised on December 2, 2020 (the “Prior Agreement”) and (ii) any other offer letter, employment agreement or severance agreement.
LEASE ONE FEDERAL, L.P., a Delaware Limited Partnership Landlord and CENTESSA PHARMACEUTICALS, INC., a Delaware corporation Tenant for Premises on 38th Floor One Federal Street Boston, Massachusetts February 7, 2022Lease Agreement • March 30th, 2022 • Centessa Pharmaceuticals PLC • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 30th, 2022 Company Industry JurisdictionTHIS LEASE is made as of the ___ day of January, 2022 (“Effective Date”), between ONE FEDERAL, L.P. (“Landlord”), a Delaware limited partnership, and CENTESSA PHARMACEUTICALS, INC. (“Tenant”), a Delaware corporation.
AMENDMENT TO NOTE PURCHASE AGREEMENT AND WAIVERNote Purchase Agreement • March 30th, 2022 • Centessa Pharmaceuticals PLC • Pharmaceutical preparations • New York
Contract Type FiledMarch 30th, 2022 Company Industry JurisdictionThis Amendment to the Note Purchase Agreement (as defined below) and Waiver (this “Amendment”) is entered into by and among Centessa Pharmaceuticals plc, a public company incorporated under the laws of England & Wales (“Issuer”), the undersigned Guarantors (together with Issuer, the “Obligors”), Three Peaks Capital Solutions Aggregator Fund (“Purchaser”) and Cocoon SA LLC, as agent for the Purchasers (“Purchaser Agent”), effective as of February 11, 2022.